Universitätsklinikum Regensburg

Late Non-Relapse Mortality (NRM) after Standard-of-Care (SOC) CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Frequency, Causes, and Risk Factors.a GLA/DRST Real World Analysis (2021) Dreger P, Schubert ML, Holtick U, Subklewe M, Von Bastian T, Ayuk FA, Wagner EM, et al. Conference contribution Standard of Care CAR-T Cell Therapy for Large B-Cell Lymphoma (LBCL): Does Bridging Efficacy Matter? a German GLA/DRST Real World Analysis (2021) Bethge WA, Martus P, Schmitt M, Holtick U, Borchmann P, Subklewe M, Rejeski K, et al. Conference contribution Prognostic Value of Elafin in Acute Graft-Versus-Host Disease (2021) Zewde MG, Morales G, Gandhi I, Ozbek U, Aguayo-Hiraldo P, Ayuk FA, Baez J, et al. Conference contribution A prediction model for the decline in renal function in people with type 2 diabetes mellitus: study protocol. (2021) Gregorich M, Heinzel A, Kammer M, Meiselbach H, Böger CA, Mayer G, Heinze G, et al. Journal article Phantom study for comparison between computed tomography- and C-Arm computed tomography-guided puncture applied by residents in radiology (2021) Meine TC, Hinrichs JB, Werncke T, Afat S, Biggemann L, Bucher A, Buettner M, et al. Journal article The New Old CD8+ T Cells in the Immune Paradox of Pregnancy (2021) Hardardottir L, Bazzano MV, Glau L, Gattinoni L, Koeninger A, Tolosa E, Solano ME Journal article, Review article Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone (2021) Siska PJ, Decking SM, Babl N, Matos C, Bruss C, Singer K, Klitzke J, et al. Journal article Emergency Use of Convalescent Plasma: Perception of the Regulatory Framework from a Clinical Perspective (2021) Mohnle P, Humpe A, Boeck M, Gruetzner S, Hackstein H, Offner R, Hildebrandt M Journal article, Review article Siglec-6 is a novel target for CAR T-cell therapy in acute myeloid leukemia (2021) Jetani H, Navarro-Bailón A, Maucher M, Frenz S, Verbruggen C, Yeguas A, Vidriales MB, et al. Journal article Increased Levels of sCD30 Have No Impact on the Incidence of Early ABMR and Long-Term Outcome in Intermediate-Risk Renal Transplant Patients With Preformed DSA (2021) Drasch T, Bach C, Luber M, Spriewald B, Utpatel K, Büttner-Herold M, Banas B, Zecher D Journal article